undefined

Ken Galbraith

Biotech executive and investor serving as President, CEO, and Board Chair of Zymeworks, with decades of experience founding and leading life sciences companies and structuring partnerships and platform-based drug development.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app